Edward Morrow Atkinson III insider trades: Vertex Pharmaceuticals Inc / Ma (VRTX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Edward reports to the SEC
Open-market buys and sales
14 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | VRTX | ↓ Sell | 668 | $486.35 | $325K | Direct | Feb 26, 2026 (1d) |
| Feb 18, 2026 | VRTX | ↓ Sell | 2,848 | $484.93 | $1.4M | Direct | Feb 19, 2026 (1d) |
| Feb 11, 2026 | VRTX | ↓ Sell | 1,751 | $460.43 | $806K | Direct | Feb 12, 2026 (1d) |
| Nov 17, 2025 | VRTX | ↓ Sell | 2,500 | $434.58 | $1.1M | Direct | Nov 19, 2025 (2d) |
| Feb 27, 2025 | VRTX | ↓ Sell | 2,650 | $475.34 | $1.3M | Direct | Feb 28, 2025 (1d) |
| Feb 25, 2025 | VRTX | ↓ Sell | 1,767 | $480.95 | $850K | Direct | Feb 26, 2025 (1d) |
| Feb 11, 2025 | VRTX | ↓ Sell | 1,747 | $459.83 | $803K | Direct | Feb 12, 2025 (1d) |
| Jun 12, 2024 | VRTX | ↓ Sell | 7,288 | $478.00 | $3.5M | Direct | Jun 13, 2024 (1d) |
| Feb 26, 2024 | VRTX | ↓ Sell | 883 | $425.70 | $376K | Direct | Feb 27, 2024 (1d) |
| Feb 21, 2024 | VRTX | ↓ Sell | 1,201 | $421.77 | $507K | Direct | Feb 23, 2024 (2d) |
| Feb 20, 2024 | VRTX | ↓ Sell | 801 | $420.79 | $337K | Direct | Feb 21, 2024 (1d) |
| Feb 12, 2024 | VRTX | ↓ Sell | 913 | $420.24 | $384K | Direct | Feb 13, 2024 (1d) |
| Jun 1, 2023 | ETNB | ↓ Sell10b5-1 | 6,250 | $17.91 | $112K | Direct | Jun 5, 2023 (4d) |
| Mar 1, 2023 | ETNB | ↓ Sell10b5-1 | 10,000 | $13.60 | $136K | Direct | Mar 3, 2023 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other VRTX insiders
Open-market trades in the last 12 months
About Edward Morrow Atkinson III's insider trades
Edward Morrow Atkinson III is EVP, Chief Technical Ops. Off. at Vertex Pharmaceuticals Inc / Ma (VRTX). Since Mar 1, 2023, Edward has reported no open-market purchases and 14 sales worth $11.8M on SEC Form 4. In the last 12 months: 4 sales ($3.6M).
2 sales (2% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include shares withheld for taxes (12 filings), grants and awards (9 filings), option exercises (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VRTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.